2019
DOI: 10.1039/c9na00571d
|View full text |Cite
|
Sign up to set email alerts
|

Tuning the cationic interface of simple polydiacetylene micelles to improve siRNA delivery at the cellular level

Abstract: Polydiacetylene micelles, bearing different cationic head groups, were systematically investigated for their ability to efficiently deliver functional siRNAs to cells.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
6
1

Relationship

4
3

Authors

Journals

citations
Cited by 8 publications
(4 citation statements)
references
References 43 publications
(25 reference statements)
0
4
0
Order By: Relevance
“…Liposomes represent successful delivery systems that have already made their way to the market as lipid-based siRNA delivery vectors siRNA viz. such as Lipofectamine, Oligofectamine, RNAifect, etc. have been applied for the delivery of siRNA.…”
Section: Introductionmentioning
confidence: 99%
“…Liposomes represent successful delivery systems that have already made their way to the market as lipid-based siRNA delivery vectors siRNA viz. such as Lipofectamine, Oligofectamine, RNAifect, etc. have been applied for the delivery of siRNA.…”
Section: Introductionmentioning
confidence: 99%
“…Polydiacetylene micelles (pDA-micelles) have been thoroughly investigated by some of us as nanometric carriers for in vivo imaging 11 and drug delivery. 12 Compared to their non-polymerized counterparts, pDA-micelles are more stable, have higher loading capacity and exhibit reduced cytotoxicity (little to no effect on mitochondrial activity, membrane permeabilization, apoptosis/necrosis, secretion of pro-inflammatory cytokines or genotoxicity). 13 In addition, pDA-micelles are compact structures which may be advantageous with regard to diffusion and uptake into atherosclerotic plaques.…”
Section: Resultsmentioning
confidence: 99%
“…14 2.8. Micelles for siRNA transfection 15 In addition to conventional chemotherapeutics, small interfering RNAs (siRNAs) and their gene silencing properties have recently attracted attention for the treatment of diseases such as cancer. Therapeutic efficacy of siRNAs depends largely on their active transfection, as free nucleic acid do not freely pass cell membranes.…”
Section: Synlett Accountmentioning
confidence: 99%